Skip to content
Telehealth Graded

NativeMed review

NativeMed's semaglutide card says $149. Click the monthly tab and it is $179; tirzepatide goes from $183 to $259. Both headlines are three-month prepay rates.

Pricing grade
CCaveat
Monthly price
$179/mo
compounded semaglutide, month to month
Price comparison
+$30 a month
See pricing details
FDA warning letter
Yes

Pricing transparency · How we grade · How we verify prices

What they advertise, what you pay
$149
the price on the compounded semaglutide card
$179
a month if you are not prepaying three
+$30 a month

The $149 is the three-month starter billed $449 upfront. The month-to-month rate is $179, and it does not appear until you click the MONTHLY tab.

  • Advertised $149, published $179
  • Month-to-month price published
  • Coverage not verified

The verdict

The real month-to-month rate exists and is fair. It just is not the number on the card, and it appears only after you click a tab.

Quick facts

Key facts

Semaglutide, month to month
$179, first month $159
Semaglutide, three-month starter
$149 a month, $449 upfront
Tirzepatide, month to month
$259, first month $199
Tirzepatide, three-month starter
$183 a month, $549 upfront
NAD+ injection
$189 monthly, or $159 on the three-month plan
Price by dose?
No. Same price at every dose
States served
Not published on any page we read

Pros and cons

What we like

  • The struck-through regular prices are shown, not implied: $299 for semaglutide and $399 for tirzepatide sit beside the sale figures.
  • The month-to-month rate does exist, and it names its own first-month discount rather than burying it.
  • The NAD+ page prints its monthly plan at $189 and its three-month plan at $159 together, with the $479 total attached.
  • The terms of service name the company and a Miami street address, which many sellers we review do not.

What could be better

  • Both GLP-1 cards lead with a prepay rate. The one-month figure is hidden behind a tab until you click it.
  • The tirzepatide gap is $183 advertised against $259 actual — one of the largest advertised-to-actual gaps among the sellers we review.
  • No state list anywhere, and no statement of where the pharmacy network can ship.
  • The homepage sale banner promises savings without naming the rate the saving is measured against.

What it is

A compounded GLP-1 seller with a short catalog — semaglutide, tirzepatide, NAD+, and three generics — sold as monthly subscriptions with the provider visit folded in. It is the compounded side of this market rather than the branded pens, and it says so on every product page.

Everything is priced per product rather than per dose, and the pages say the price holds at any dose. The NAD+ line runs beside the weight-loss one on the same checkout.

Every price we found at NativeMed

PlanAdvertisedPublished priceThe gap
Compounded semaglutide, month to monthCancel anytime. First month $159. The $149 belongs to the three-month starter.$149$179
+$30
Compounded semaglutide, three-month starter$449 paid upfront for three months.not published$149not comparable
Compounded tirzepatide, month to monthCancel anytime. First month $199.$183$259
+$76
Compounded tirzepatide, three-month starter$549 paid upfront for three months.not published$183not comparable
NAD+ injectionMonthly. The three-month plan is $479, which the page prints as $159 a month.not published$189not comparable

What it actually costs at NativeMed

The $149 on the semaglutide card is the three-month starter, billed $449 upfront. Month to month is $179, with a $159 first month, and that number appears only after you click the MONTHLY tab.

Tirzepatide splits the same way and wider: $183 advertised, $549 upfront for three months, against $259 a month with a $199 first month. That is a prepay rate wearing a monthly label all over again.

NAD+ is handled better. Its plan block prints $189 a month and $159 a month on the three-month plan at $479 side by side, with no clicking required.

Who it's wrong for

Medications available

  • Compounded semaglutideCompounded
    $179 a month, or $149 on the three-month starter

    Same price at every dose. First month $159 on the monthly plan.

  • Compounded tirzepatideCompounded
    $259 a month, or $183 on the three-month starter

    First month $199 on the monthly plan.

  • NAD+ injectionCompounded
    $189 a month

    One concentration. The three-month plan is $479.

Is NativeMed legit?

NativeMed is operated by NativeMed, LLC, 66 W Flagler Street, Suite 900, Miami, FL 33130, according to its terms of service.

  • FDA warning letter June 8, 2026 — about product photos with its name on the label, which FDA said suggested it compounded the drugs, and a claim that its compounded semaglutide has "the same active ingredient in Ozempic and Wegovy". Read the letter →

Pharmacy, prescribers and safety checks

  • Who prescribesNetwork providers, named as a separate medical practice in the terms
  • Pharmacy namedNot disclosed. The pages say only that pharmacies are accredited
  • Lot testingThe NAD+ page states potency, sterility, pH and endotoxin testing by registered labs
  • Compounded disclosurePresent. The FDA does not review compounded medications, stated on the product page
  • States servedNot published

Common questions

How much is NativeMed semaglutide per month?

$179 a month if you pay monthly, with a $159 first month. The $149 the product card advertises is the three-month starter plan, billed $449 upfront.

Why does the price change when I click a different tab?

The card defaults to the three-month starter. Clicking MONTHLY replaces the number with the month-to-month rate, which is $179 for semaglutide and $259 for tirzepatide.

Does the price go up as my dose increases?

No. Both GLP-1 pages state the same price applies at every dose, and no dose ladder appears anywhere on the pages we read.

Which states does NativeMed serve?

It does not say. We read five pages, including both GLP-1 product pages and the terms of service, and none of them names a state or describes where it can ship.

Why we gave NativeMed a C

Read the full grading rationale

Both GLP-1 cards lead with three-month starter plans — semaglutide $149, tirzepatide $183, billed $449 and $549 upfront — and say so beside the number. The month-to-month rate appears only after you click the MONTHLY tab: $179 for semaglutide with a $159 first month, $259 for tirzepatide with a $199 first month. Plan totals and the NAD+ monthly price of $189 are shown plainly. The terms name the company and a Miami street address. No state list.

Read the evidence

How we reviewed NativeMed

We read NativeMed's two GLP-1 pages, its NAD+ page and its terms of service.

The month-to-month prices appear only after you click the MONTHLY tab on each GLP-1 page, so that is where we read them.

Where each price comes from
  • Semaglutide page
    SELECT PROGRAM 3 MONTH STARTER MONTHLY $328 LESS $149/mo | $449 PAID UPFRONT
  • Tirzepatide page
    SELECT PROGRAM 3 MONTH STARTER MONTHLY $508 LESS $183/mo | $549 PAID UPFRONT
  • Nad page
    Monthly PLAN NAD+ Ideal for both frequent users and those starting slower — one powerful concentration that fits all routines $189/mo

Alternatives to NativeMed

ProviderGradePublished price context
Vytora HealthCCaveatFrom $179/mo for compounded semaglutide, month to month
BrightmedsAVerifiedFrom $129/mo for compounded semaglutide, month to month
OurView HealthBMinor gapFrom $109/mo for compounded semaglutide, month to month
Bodybuilding Health+CCaveatFrom $279/mo for compounded semaglutide, month to month
WeightCareCCaveatFrom $399/mo for compounded semaglutide, month to month